Rhenman & Partners Asset Management AB
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1599882
Stockholm, V7
Position in IOVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,214,197
+$2,858,955 QoQ
Shares Held
2,055,327
+28.8% QoQ
Ownership
0.460%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. IOVA ranks #15 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,100 | $37,163,984 | |
| 2 | INSM |
INSMED Inc
|
159,760 | $26,123,955 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,485 | $19,417,791 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
75,890 | $14,347,004 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
24,050 | $12,589,453 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
207,000 | $11,693,430 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,465 | $11,403,434 | |
| 8 | RPRX |
Royalty Pharma plc
|
233,000 | $11,177,010 |
All Filings in IOVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,214,197 | 2,055,327 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,355,242 | 1,595,327 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,382,284 | 1,097,827 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,114,262 | 647,827 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,157,263 | 647,827 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,142,315 | 1,235,448 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,882,975 | 1,052,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,378,400 | 920,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,153,100 | 955,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,079,730 | 1,116,818 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,322,500 | 950,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,984,000 | 850,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,192,498 | 686,170 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,523,375 | 864,378 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,885,800 | 510,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,851,200 | 530,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,908,750 | 475,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,454,000 | 600,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,891,200 | 320,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,806,000 | 300,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,339,700 | 295,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $14,848,000 | 320,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $11,192,800 | 340,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $9,333,000 | 340,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $10,928,100 | 365,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||